##gff-version 3
##sequence-region O15399 1 1336
O15399	UniProtKB	Signal peptide	1	27	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15399	UniProtKB	Chain	28	1336	.	.	.	ID=PRO_0000011583;Note=Glutamate receptor ionotropic%2C NMDA 2D	
O15399	UniProtKB	Topological domain	28	584	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Transmembrane	585	603	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Topological domain	604	630	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Intramembrane	631	650	.	.	.	Note=Discontinuously helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Topological domain	651	657	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Transmembrane	658	673	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Topological domain	674	844	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Transmembrane	845	864	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Topological domain	865	1336	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Region	539	541	.	.	.	Note=Glutamate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
O15399	UniProtKB	Region	631	650	.	.	.	Note=Pore-forming;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Region	717	718	.	.	.	Note=Glutamate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
O15399	UniProtKB	Motif	1334	1336	.	.	.	Note=PDZ-binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O15399	UniProtKB	Compositional bias	281	286	.	.	.	Note=Poly-Gly	
O15399	UniProtKB	Compositional bias	908	916	.	.	.	Note=Poly-Pro	
O15399	UniProtKB	Compositional bias	1035	1040	.	.	.	Note=Poly-Ala	
O15399	UniProtKB	Compositional bias	1209	1213	.	.	.	Note=Poly-Pro	
O15399	UniProtKB	Compositional bias	1244	1247	.	.	.	Note=Poly-Ala	
O15399	UniProtKB	Binding site	541	541	.	.	.	Note=Glutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Binding site	546	546	.	.	.	Note=Glutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Binding site	759	759	.	.	.	Note=Glutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
O15399	UniProtKB	Site	642	642	.	.	.	Note=Functional determinant of NMDA receptors;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O15399	UniProtKB	Modified residue	1316	1316	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q03391	
O15399	UniProtKB	Modified residue	1326	1326	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q03391	
O15399	UniProtKB	Glycosylation	92	92	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15399	UniProtKB	Glycosylation	352	352	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15399	UniProtKB	Glycosylation	366	366	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15399	UniProtKB	Glycosylation	467	467	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15399	UniProtKB	Glycosylation	569	569	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15399	UniProtKB	Disulfide bond	104	348	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
O15399	UniProtKB	Disulfide bond	455	483	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
O15399	UniProtKB	Disulfide bond	462	484	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
O15399	UniProtKB	Disulfide bond	773	828	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
O15399	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_035698;Note=In a breast cancer sample%3B somatic mutation. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
O15399	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_035699;Note=In a breast cancer sample%3B somatic mutation. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs1259830926,PMID:16959974	
O15399	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_079975;Note=Found in a patient with schizophrenia%3B unknown pathological significance. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
O15399	UniProtKB	Natural variant	527	527	.	.	.	ID=VAR_035700;Note=In a breast cancer sample%3B somatic mutation. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
O15399	UniProtKB	Natural variant	592	592	.	.	.	ID=VAR_079976;Note=Found in a patient with autism spectrum disorder%3B unknown pathological significance. M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
O15399	UniProtKB	Natural variant	667	667	.	.	.	ID=VAR_077103;Note=In EIEE46%3B gain-of-function mutation that potentiates ionotropic glutamate receptor signaling%3B mutant receptors are activated by lower concentrations of glutamate and glycine and show slower deactivation after agonist removal as well as decreased sensitivity to allosteric inhibitors indicating that NMDA glutamate receptor activity is changed. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27616483;Dbxref=dbSNP:rs886040861,PMID:27616483	
O15399	UniProtKB	Natural variant	733	733	.	.	.	ID=VAR_079977;Note=Found in a patient with schizophrenia%3B unknown pathological significance. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
O15399	UniProtKB	Natural variant	872	872	.	.	.	ID=VAR_079978;Note=Found in a patient with schizophrenia%3B unknown pathological significance. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs750543659,PMID:22833210	
O15399	UniProtKB	Natural variant	883	883	.	.	.	ID=VAR_079979;Note=M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs781567305,PMID:22833210	
O15399	UniProtKB	Natural variant	922	922	.	.	.	ID=VAR_079980;Note=Found in patients with schizophrenia%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs571334598,PMID:22833210	
O15399	UniProtKB	Natural variant	926	926	.	.	.	ID=VAR_079981;Note=Found in a patient with autism spectrum disorder%3B unknown pathological significance. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
O15399	UniProtKB	Natural variant	982	982	.	.	.	ID=VAR_079982;Note=A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs1225338399,PMID:22833210	
O15399	UniProtKB	Natural variant	1317	1317	.	.	.	ID=VAR_079983;Note=G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs191119443,PMID:22833210	
O15399	UniProtKB	Mutagenesis	580	580	.	.	.	Note=Changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
O15399	UniProtKB	Mutagenesis	845	845	.	.	.	Note=Increased glutamate and glycine agonist potency. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28126851;Dbxref=PMID:28126851	
O15399	UniProtKB	Sequence conflict	924	924	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O15399	UniProtKB	Sequence conflict	1005	1005	.	.	.	Note=P->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O15399	UniProtKB	Sequence conflict	1097	1097	.	.	.	Note=R->C;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O15399	UniProtKB	Sequence conflict	1130	1130	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
